KOSDAQ - Delayed Quote KRW

BIO-FD&C Co.,Ltd. (251120.KQ)

Compare
13,270.00 +320.00 (+2.47%)
At close: 3:30 PM GMT+9
Loading Chart for 251120.KQ
DELL
  • Previous Close 12,950.00
  • Open 13,200.00
  • Bid 13,260.00 x --
  • Ask 13,270.00 x --
  • Day's Range 13,110.00 - 13,700.00
  • 52 Week Range 12,090.00 - 19,150.00
  • Volume 38,890
  • Avg. Volume 39,929
  • Market Cap (intraday) 113.179B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, herbal extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, skin moisturizing, anti-inflammation/skin soothing, and anti-oxidation. The company was founded in 2005 and is headquartered in Incheon, South Korea.

www.biofdnc.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 251120.KQ

View More

Performance Overview: 251120.KQ

Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

251120.KQ
6.02%
KOSPI Composite Index
5.80%

1-Year Return

251120.KQ
5.48%
KOSPI Composite Index
0.42%

3-Year Return

251120.KQ
47.34%
KOSPI Composite Index
8.84%

5-Year Return

251120.KQ
47.34%
KOSPI Composite Index
8.84%

Compare To: 251120.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 251120.KQ

View More

Valuation Measures

Annual
As of 11/20/2024
  • Market Cap

    113.95B

  • Enterprise Value

    71.29B

  • Trailing P/E

    22.34

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.09

  • Price/Book (mrq)

    1.86

  • Enterprise Value/Revenue

    4.44

  • Enterprise Value/EBITDA

    9.44

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    31.74%

  • Return on Assets (ttm)

    4.75%

  • Return on Equity (ttm)

    8.67%

  • Revenue (ttm)

    16.07B

  • Net Income Avi to Common (ttm)

    5.1B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    44.01B

  • Total Debt/Equity (mrq)

    2.21%

  • Levered Free Cash Flow (ttm)

    3.33B

Research Analysis: 251120.KQ

View More

Company Insights: 251120.KQ

Research Reports: 251120.KQ

View More